Treatment with cisplatin alone did not show any significant (P < 0.05) change in IL-6 levels; however, treatment with combination of cisplatin with telmisartan showed significant (P < 0.05) decrease in IL-6 level in cancer treated rats as compared to cancer control rats (Figure 3(b)). This evidence concerns the gene IL6 and cancer.